Prevention of adjuvant arthritis in rats by a nonapeptide from the 65‐kD mycobacterial heat‐shock protein
Adjuvant arthritis in Lewis rats is a model of T cell‐mediated autoimmune arthritis resembling human rheumatoid arthritis. A nonapeptide from the 65‐kD heat‐shock protein of Mycobacterium bovis BCG, amino acid sequence 180–188, has been described to carry the dominant immunogenic epitope(s) for both arthritis‐protective and arthritogenic T cell clones. Here we demonstrate that immunizations with the synthetic nonapeptide completely protected rats against adjuvant arthritis induced by M. tuberculosis. Interestingly, deletion of the N‐teminal threonine of the nonapeptide resulted in loss of the protective activity. Pretreatments with the nonapeptide resulted in an immune response to the nonapeptide and to M. tuberculosis. After immunizations with the synthetic nonapeptide, only low titres of nonapcptidc‐spccific antibodies were produced, whereas a significant cellular immune response to the nonapeptide was observed. In addition, the protection was transferable to naive rats by spleen T cells. These findings document the requirement of a T cell‐specific immune response to the dominant epitope of the 65‐kD mycobacterial heat‐shock protein for the protection against adjuvant arthritis and suggest the feasibility of immune intervention in autoimmune arthritis through the use of synthetic peptides.